Zealand Pharma — Marts 2022
-
Video - TA på Novo Nordisk
- Zealand Pharma
- Genmab
- Bavarian https://www.proinvestor.com/boards/102346/4-efterspurgte-danske-aktier-med-TA-FA
-
Kort video: Jeg orienterer om overflytningen af ProInvestor til en ny platform. Der lys forude. :−) I disse tider med krig, rentestigninger osv. kan det være svært at navigere som aktieinvestor. Jeg guider til gode input ift. situationen i Ukraine og Rusland og inspiration til, hvad man kan gøre med sin portefølje i en svær tid, med Hans-Henrik Nielsen fra Markettimer. https://www.proinvestor.com/boards/102348
-
SUPPORT-ABONNEMENT - Støt
Proinvestor.com: https://www.proinvestor.com/donation -
SUPPORT-ABONNEMENT - Støt Proinvestor.com: https://www.proinvestor.com/donation
-
clinicaltrials.gov Status: Not yet recruiting First Posted: March 25, 2022 (Phase 1)
"A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906"
-
tak - god w/e
-
@Svingtraderen - tak, god weekend!
-
lad os håbe det - kursen performer godt i dag - happy friday:)
-
"Fedme klinger i kassen hos Novo Nordisk: Kan være over 500 mia. kr. værd"
Fandt online version her:
Fedme klinger i kassen hos Novo Nordisk: Kan være over 500 mia. kr. værd
Fedme er en afgørende vækstskaber og et enormt marked for Novo Nordisk i det kommende årti Det er et langt, sejt træk at åbne markedet for salg af fedmemedicin. Får Novo Nordisk succes med det, står m
borsen.dk (borsen.dk)
-
NBI ved at bunde ud https://www.proinvestor.com/boards/102420/NBI-ved-at-bunde-ud
-
Zealand Pharma Appoints New Chief Executive Officer, Refocuses Strategy to Prioritize Research & Development and Streamlines Operations
Company announcement – No. 10 / 2022 Zealand Pharma Appoints New Chief Executive Officer, Refocuses Strategy to Prioritize Research &...
GlobeNewswire News Room (www.globenewswire.com)
-
Dr. Adam Steensberg assumes the position of Chief Executive Office refocusing Zealand to better leverage its next-generation peptide platform to address unmet medical needs of patients
Commercial operations restructured to pursue partnerships for Zegalogue, V-Go and the glepaglutide and dasiglucagon late-stage clinical portfolio
Annual operating expense reductions to be at least 35% from 2021 levels
Conference call for investors and financial community will be held today at 4:30 PM CET/ 10:30 AM -
Det lugter af en fejlslagen strategi med opkøbet af V-go? og så skal Adam da straks ud og købe nogle nye aktier efter han fik solgt ud før nedturen.
-
Men ja, kæmpe overraskelse. Men er det positivt op til forventet Q2 og Q3-svar eller kommer der forsinkelse og/eller negative svar på studierne?
Alt kan ske Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind